Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02045589
What this trial is testing

A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaMetastatic Pancreatic Adenocarcinoma
Theriva Biologics SL 8
Testing effectiveness (Phase 2)Ended earlyNCT05275478
What this trial is testing

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Tango Therapeutics, Inc. 110
Testing effectiveness (Phase 2)UnknownNCT02739633
What this trial is testing

Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
Recurrent Adenocarcinoma of the PancreasMetastatic Adenocarcinoma of the Pancreas
Samyang Biopharmaceuticals Corporation 47
Testing effectiveness (Phase 2)Ended earlyNCT00429858
What this trial is testing

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Andrew Ko 21
Testing effectiveness (Phase 2)Study completedNCT05068752
What this trial is testing

Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer

Who this might be right for
Pancreas Cancer
HonorHealth Research Institute 10
Large-scale testing (Phase 3)UnknownNCT00268411
What this trial is testing

Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04098081
What this trial is testing

1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic Cancer
University of Maryland, Baltimore 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765836
What this trial is testing

Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PC

Who this might be right for
Pancreatic Cancer Metastatic
Massachusetts General Hospital 40
Early research (Phase 1)Ended earlyNCT05484011
What this trial is testing

A Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
HiberCell, Inc. 5
Testing effectiveness (Phase 2)Looking for participantsNCT06790602
What this trial is testing

Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)
University of California, San Diego 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT01585805
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 83
Large-scale testing (Phase 3)UnknownNCT06018883
What this trial is testing

Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Fudan University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06843551
What this trial is testing

The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Cancer
Benjamin Spieler 20
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Testing effectiveness (Phase 2)UnknownNCT04672005
What this trial is testing

Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Lyudmyla Berim 30
Testing effectiveness (Phase 2)Looking for participantsNCT07226856
What this trial is testing

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Mayo Clinic 43
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07344220
What this trial is testing

Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate

Who this might be right for
Metastatic Pancreatic AdenocarcinomaPancreatic Cancer
Hoag Memorial Hospital Presbyterian 39
Testing effectiveness (Phase 2)Study completedNCT01415713
What this trial is testing

The Study of Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
National Health Research Institutes, Taiwan 73
Early research (Phase 1)Looking for participantsNCT07094113
What this trial is testing

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Who this might be right for
KRAS Altered Advanced or Metastatic Solid Tumors
Amgen 434
Testing effectiveness (Phase 2)Active Not RecruitingNCT05094336
What this trial is testing

Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

Who this might be right for
Advanced MTAP-null Solid Tumors
Amgen 329
Next Page